Table 2. Top public-private partnerships in 2013 by value. Public-private partnerships (PPPs) that include grants, awards and/or other types of direct funding support from national governments and/or government institutions are included in the 2013 list but are ranked separately from those without such support. Only 90 of the 301 PPPs reported in 2013 had disclosed dollar amounts. Excludes deals that only involve IP transfer.

Source: BioCentury Archives

Companies

Institutions

Disclosed value ($M)

PPPs without direct support from national governments and/or government institutions

AstraZeneca plc (LSE:AZN; NYSE:AZN)

Karolinska Institute

$20 per year

Takeda Pharmaceutical Co. Ltd. (Tokyo:4502)

Memorial Sloan Kettering Cancer Center; The Rockefeller University; Weill Cornell Medical College

$20 plus
$1.5 per year

Not applicable

Canadian Partnership Against Cancer; Heart and Stroke Foundation

C$16 ($15.3)

Illumina Inc. (NASDAQ:ILMN); Intel Corp. (NASDAQ:INTC)

Oregon Health & Science University; Leukemia & Lymphoma Society; Stanford University; The University of Texas Southwestern Medical Center; The University of Utah

$8.2

Sarepta Therapeutics Inc. (NASDAQ:SRPT)

The University of Western Australia

$7.1

PPPs with direct support from national governments and/or government institutions

Celgene Corp. (NASDAQ:CELG); Eli Lilly and Co. (NYSE:LLY); General Electric Co. (NYSE:GE); undisclosed VC partners

New York City Economic Development Corp.

$100

GlaxoSmithKline plc (LSE:GSK; NYSE:GSK);
Merck & Co. Inc.
(NYSE:MRK); Pfizer Inc. (NYSE:PFE); JPMorgan Chase & Co. (NYSE:JPM); Lion's Head Global Partners LLP

Bill & Melinda Gates Foundation; Children's Investment Fund Foundation; Federal Ministry for Economic Cooperation and Development; Grand Challenges Canada; Swedish International Development Cooperation Agency

$94

AbbVie Inc. (NYSE:ABBV); Boehringer Ingelheim GmbH; Eli Lilly; GlaxoSmithKline; Johnson & Johnson (NYSE:JNJ); Novartis AG (NYSE:NVS; SIX:NOVN); Pfizer; Takeda Pharmaceutical

Li Ka Shing Foundation; University of Oxford; U.K. government

£40 ($61.8) plus a one-time payment of $8

Eli Lilly; Roche (SIX:ROG; OTCQX:RHHBY); Biomet Inc.; BioCrossroads; Cook Group Inc.; Dow Chemical Co. (NYSE:DOW)

Indiana University; Purdue University; University of Notre Dame

$50A

Caprion Proteomics Inc.; Oncozyme Pharma Inc.; Pfizer; Sanofi (Euronext:SAN; NYSE:SNY)

Quebec Clinical Research Organization in Cancer; TELUS Health

C$21.1 ($20.9)

AReflects initial amount, but PPP will seek another $310 million in capital funding from corporate and philanthropic sources.